Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Squamous Cell of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT04144140
What this trial is testing

Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101

Who this might be right for
LymphomaAdvanced Solid Tumors
Eisai Inc. 24
Not applicableUnknownNCT02126189
What this trial is testing

The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study

Who this might be right for
Head and Neck Squamous Cell CarcinomaHuman Papillomavirus
Queensland Centre of Excellence for Head and Neck Cancer 600
Not applicableLooking for participantsNCT06947668
What this trial is testing

Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Who this might be right for
Squamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of the HypopharynxLarynx Squamous Cell Carcinoma+1 more
University of Erlangen-Nürnberg Medical School 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT05343325
What this trial is testing

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University 25
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Not applicableStudy completedNCT00160095
What this trial is testing

Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas

Who this might be right for
Larynx Cancer
Radboud University Medical Center 79
Early research (Phase 1)WithdrawnNCT01491139
What this trial is testing

Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
University College, London
Testing effectiveness (Phase 2)UnknownNCT01391572
What this trial is testing

A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 300
Early research (Phase 1)Study completedNCT01758731
What this trial is testing

Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Colorado, Denver 17
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT01252628
What this trial is testing

Phase 1 and 2 Study of PX-866 and Cetuximab

Who this might be right for
Incurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cascadian Therapeutics Inc. 178
Testing effectiveness (Phase 2)Study completedNCT00508664
What this trial is testing

Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)

Who this might be right for
Squamous Cell Carcinoma of the HypopharynxLarynx Carcinoma
ClinAssess 180
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Large-scale testing (Phase 3)Study completedNCT01427478
What this trial is testing

Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Centre Leon Berard 134
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Testing effectiveness (Phase 2)WithdrawnNCT04093115
What this trial is testing

Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Beijing Konruns Pharmaceutical Co., Ltd.
Not applicableEnded earlyNCT03412058
What this trial is testing

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
UNICANCER 152
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00116909
What this trial is testing

OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Who this might be right for
Locally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy
OSI Pharmaceuticals 85
Not applicableNot Yet RecruitingNCT07674706
What this trial is testing

Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers

Who this might be right for
XerostomiaHead CancerNeck Cancer+3 more
National University Hospital, Singapore 50
Next Page